InterShunt Technologies
PrivateLast Round
Series B
Aug 13, 2024
Total Funding Raised
$18.3M
Company Overview
InterShunt Technologies operates in Healthcare & Life Sciences and is based in Maple Grove, Minnesota. Its latest recorded funding round was a Series B round in August 2024.
InterShunt Technologies is a medical device company developing a proprietary, minimally invasive transcatheter system to create an interatrial shunt for relieving elevated left atrial pressure in heart failure patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InterShunt Technologies Comparables
Compare InterShunt Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alleviant Medical | 88% | |
| Hangzhou NOYA MedTech Co., Ltd. | 84% | |
| Corvia Medical | 83% |
For institutional investors. Book with your work email.
InterShunt Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 13, 2024 | ||||
| Series A | Jan 11, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
InterShunt Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Solas BioVentures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 13, 2024
$18.3M round completed.
For institutional investors. Book with your work email.
InterShunt Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about InterShunt Technologies's valuation, stock price, and market status.
Is InterShunt Technologies a public or private company?
InterShunt Technologies is a private company.
What is the current stock price of InterShunt Technologies?
InterShunt Technologies is a private company, so its shares have no public market price. Caplight tracks InterShunt Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is InterShunt Technologies worth (valuation)?
Valuation information for InterShunt Technologies is not publicly available.
Can I buy InterShunt Technologies stock?
InterShunt Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was InterShunt Technologies's last funding round?
InterShunt Technologies's most recent funding round was Series B on August 13, 2024.
Who are the main investors in InterShunt Technologies?
Key investors in InterShunt Technologies include Solas BioVentures.
Will InterShunt Technologies IPO soon?
No public IPO plans have been announced for InterShunt Technologies.
How can I track InterShunt Technologies secondary market activity?
Caplight tracks bids, offers, and trades in InterShunt Technologies's shares on secondary markets.